Senior Director, Global Market Access Strategy
Cambridge, MA, United States
The Senior Director, Global Market Access Strategy (GMAX) drives market access strategy for Sarepta's assets with influential leadership that represent the goals and priorities of the broader International Business Unit to cross functional teams such as the Global Product Team (GPT) or Customer Org Sub-Team (CT). This role is responsible for developing market access and evidence generation strategies, communicating the vision and mission of the function, working with HEOR team members to drive evidence generation activities, and communicating with internal stakeholders to ensure alignment of GMAX strategies with overall goals for Sarepta assets.
In collaboration with the broader International Business Unit, the GMAX team proactively monitors external market access / evidence generation requirements and drives development of market access strategies, including development of the global payer value proposition and evidence generation strategies for Sarepta's assets in development as well as marketed therapies, to optimize access.
Primary Responsibilities Include:
Serve as a key member and organizer of cross functional teams; contribute to continuous improvement and development of Market Access function through leadership of functional initiatives and organizational change. Effectively communicate within the organization and be the lead GMAX representative at key internal governance and executive meetings.
Partner with internal stakeholders (Commercial Brand Leads, Medical Directors, Medical Managed Care, US Market Access, Global teams, etc.) at strategic and tactical levels to generate and disseminate robust evidentiary data in support of a broad set of partners including payers. Assume financial management responsibilities, including budget planning and implementation.
Provide strategic leadership and oversight to all GMAX activities supporting value proposition, global market prioritization development, and communicating throughout the organization.
Triage incoming requests for evidence / market access support from International Business partners to ensure timely and relevant responses and lead development of internal materials (e.g. Global Value Dossier) to support local market access submissions.
Closely partner with internal cross-functional teams to enable and drive payer-centricity in all market access and HEOR research and activities supporting pipeline products across various platforms.
Role model and cultivate a culture of teamwork and coordinate with cross-functional team to ensure that patient-relevant and reimbursement-relevant endpoints are incorporated into clinical stages of product development to facilitate Sarepta development programs.
Represent HEOR / Market Access function with Alliance (Co-Development) partners (e.g. sitting on Alliance cross-functional Global Product Teams, market access sub-teams, etc).
Gather insights on evidence generation needs for key global payer / Health Technology Assessment (HTA) stakeholders, and communicate results within Sarepta: Pressure testing value assumptions and evidence requirements (testing TPP, key value drivers)
Payer inputs on value story, evidence generation plan
Global reference price tracking
Identify external market access / HEOR (or other) subject matter experts for potential research collaborations.
Lead HTA Scientific Advice activities (pre-launch) and HTA submissions (post-launch).
Represent Sarepta with external organizations (e.g. ISPOR) or consortia as appropriate.
Other related duties as needed.
Desired Education and Skills:
MS required, Doctorate in health economics, epidemiology, statistics, public health, health policy or related field preferred.
12+ years of experience in the pharma or healthcare sector, preferably in health economics, market access or related functions/fields is required with at least 3+ years of global HTA experience preferred.
Proven track record of successful collaboration with cross-functional teams.
Substantial experience in shaping market access, HEOR and RWE strategies, supporting pipeline products, is strongly preferred.
Experience working in rare disease, or cell & gene therapies, is preferred.
Substantial experience engaging or partnering with external organizations (e.g., universities, value assessors, regulatory agencies, etc.) is strongly preferred.
Excellent communication and presentation skills; fluency working with Microsoft Office.
Ability to travel up to 15%.
#LI-PM
#LI-Hybrid
This position is hybrid, you will be expected to work on site at one of Sarepta's facilities in the United States and/or attend Company-sponsored in-person events from time to time.
The targeted salary range for this position is $216,000 - $270,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta's compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity.
Candidates must be authorized to work in the U.S.
Sarepta Therapeutics offers a competitive compensation and benefit package.
Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify.
#J-18808-Ljbffr